NASDAQ:NEUP Neuphoria Therapeutics Q4 2025 Earnings Results & Report $2.29 +0.02 (+0.88%) Closing price 03:59 PM EasternExtended Trading$2.28 -0.01 (-0.44%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Neuphoria Therapeutics missed analyst earnings expectations in its Q4 2025 results, released September 29, 2025. The company reported EPS of -$5.79 versus the -$0.56 consensus estimate, while revenue was -$13.27 thousand. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2025Report DateSeptember 29, 2025TimeBefore Market OpensConference Call8:00 AM ET Neuphoria Therapeutics EPS ResultsActual EPS-$5.79Consensus EPS -$0.56Beat/MissMissed by -$5.23One Year Ago EPSN/AEPS Beat Rate3 of last 6 quartersNeuphoria Therapeutics Revenue ResultsActual Revenue-$13.27 thousandExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Annual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Annual report(10-K) Neuphoria Therapeutics Q4 2025 Earnings FAQ Did Neuphoria Therapeutics beat earnings estimates for Q4 2025? Neuphoria Therapeutics (NASDAQ:NEUP) reported earnings of -$5.79 per share for Q4 2025, missing the consensus estimate of -$0.56. The report was announced on Monday, September 29, 2025. What was Neuphoria Therapeutics' revenue for Q4 2025? Neuphoria Therapeutics reported revenue of -$13.27 thousand for Q4 2025. Neuphoria Therapeutics Earnings HeadlinesNeuphoria Therapeutics Inc. Reports Earnings Results for the First Quarter Ended September 30, 2026November 17 at 1:43 PM | marketscreener.comMNeuphoria Therapeutics Inc. enters into Amendment No. 1 to rights agreement to extend expiration date to October 27, 2027October 23, 2026 | msn.comYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.November 18 at 1:00 AM | American Alternative (Ad)Neuphoria Therapeutics Inc. Reports Earnings Results for the Full Year Ended June 30, 2026September 19, 2026 | marketscreener.comMNeuphoria Therapeutics Inc Ordinary Shares NEUPAugust 14, 2026 | morningstar.comMNeuphoria Therapeutics Inc (NEUP)August 8, 2026 | investing.comSee More Neuphoria Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Neuphoria Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neuphoria Therapeutics and other key companies, straight to your email. Email Address About Neuphoria TherapeuticsNeuphoria Therapeutics (NASDAQ:NEUP), Inc. is a clinical-stage biopharmaceutical company focused on developing investigational treatments for neurological and psychiatric conditions. The company’s work centers on advancing drug candidates intended to address needs in brain health. Its products remain in development rather than being established, marketed therapies. Publicly available information about Neuphoria’s specific development programs, operating geographies and leadership is limited, so no additional details are included here.View Neuphoria Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes ShapeGeneral Motors Faces a Cost Squeeze as Factory Automation Takes Center StageNVIDIA's Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?5 Consumer Discretionary Plays Showing Strength During the Tech Sell-OffAMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?Viking’s Low-Water Miss Looks Like a Buy-the-Dip OpportunityDisney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout Upcoming Earnings NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026)Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.